Home Weight loss (GLP-1) GLP-1 cost Changes in 2027
GLP-1 price and coverage changes in 2027: what changes on January 1
Wegovy, Ozempic and Rybelsus get a $675 list price, Medicare's negotiated semaglutide price becomes $274 for a 30-day supply in covered uses, and the $50 Medicare Bridge runs through 2027. What does not change: no maker has announced a lower 2027 cash price, and Lilly's Zepbound savings cards and Novo Nordisk's $199 Wegovy intro fills end on December 31, 2026.
Prices that don't wait for 2027: self-pay programs
Compounded semaglutide and tirzepatide, and programs that prescribe brand-name Wegovy and Zepbound, at their own monthly prices. The price tables are sorted cheapest first.
How we picked
Every program here is prescribed online by a US-licensed clinician, fills prescriptions through a licensed US pharmacy and lets you start without an office visit. Each card shows the price we read on the program's own site (or says when a program prices only after its intake) and what that price covers, and we keep the date of every read; some programs bill a membership and the medication separately, and the card says so. The label on each card says what that program stands out for. How we check prices and programs.
Compounded semaglutide: lowest monthly price
| # | Program | Lowest price | Month to month | Notes | Link |
|---|---|---|---|---|---|
| 1 | SnagRxCheapest | $59/mo | $59/mo | pre-Black Friday sale price (was $299), locked in; the page counts down to a price increase | VisitSnagRx |
| 2 | Lttl | $89/mo 12-month plan | $99 / 4 wks | 4-week supply | VisitLttl |
| 3 | yourEra | $96/mo 12-month plan | $186/mo | $1,152 billed upfront; same price at every dose; Black Friday: 25% off every plan at checkout | VisityourEra |
| 4 | HealthRX | $97/mo 12-month plan | Not offered | charged every month; $39 first month on every plan | VisitHealthRX |
| 5 | BetterMe Rx | $99/mo 12-month plan | $199/mo | VisitBetterMe Rx |
Compounded tirzepatide: lowest monthly price
| # | Program | Lowest price | Month to month | Notes | Link |
|---|---|---|---|---|---|
| 1 | yourEraCheapest | $96/mo 12-month plan | $186/mo | $1,152 billed upfront; same price at every dose; Black Friday: 25% off every plan at checkout | VisityourEra |
| 2 | Maximus | $99.99/mo 12-month plan | Not offered | paid up front; $199.99 on 2 months | VisitMaximus |
| 3 | SnagRx | $109/mo | $109/mo | pre-Black Friday sale price (was $349), locked in; the page counts down to a price increase | VisitSnagRx |
| 4 | Lttl | $139/mo 12-month plan | $149 / 4 wks | 4-week supply | VisitLttl |
| 5 | BetterMe Rx | $159/mo 12-month plan | $249/mo | VisitBetterMe Rx |
- 120-day weight-loss guarantee#1
Black Friday price locked inCompounded semaglutide from $159 a month, with a health coach included
- Black Friday: semaglutide $175/mo, tirzepatide $225/mo, billed every 2 months and locked in
- First-time GLP-1 users: lose 5% in 120 days or your money back, if you keep the coaching and check-in commitments
- Same price at every dose; under-the-tongue drops and lozenges too; HSA/FSA eligible
Comes asInjection or drops or troche
Semaglutide from$159/moon the 12-month plan ($1,908 up front); $179 on 6 months; $199 month to month (28-day billing); Black Friday $175/mo billed $350 every 2 months4.6 on Trustpilot1,084 reviews ·Visit SHED Read our SHED review - Low-cost tirzepatide#2
Same price at every doseCompounded tirzepatide from $99.99 a month
- One flat rate covers every dose, with no membership fee
- Online evaluation in about 5 minutes, no appointment needed
- Free shipping in discreet packaging, HSA/FSA accepted
Comes asVial
Tirzepatide from$99.99/moon the 12-month plan, paid up front; $199.99 on 2 months4.4 on Trustpilot1,106 reviews ·Visit Maximus Read our Maximus review - Sale price locked in#3
Pre-Black Friday sale: was $299Compounded semaglutide for $59 a month during its sale
- Tirzepatide $109/mo; same price at every dose, every month
- No membership, no hidden fees, cancel anytime
- Rx written in about a day, delivered in 1-2 days
Comes asInjection
Semaglutide$59/moduring the pre-Black Friday sale (was $299); the page counts down to a price increase and says the sale price is locked in for lifeVisit SnagRx Read our SnagRx review - Brand-name only#4
Labs every 90 days includedBrand-name GLP-1 care with quarterly labs, one flat fee
- Wegovy, Zepbound, Mounjaro or Ozempic; never compounded
- Lab panel every 90 days, monthly clinician check-ins and unlimited chat
- Medication billed by your pharmacy at its own price, no markup
Membership$299/moplus medication at pharmacy cost; 2-month start ($598 held at checkout)Visit GoodLife Read our GoodLife review - Low month-to-month#5
Up to $140 off your first monthCompounded semaglutide for $99, month to month
- Same price at every dose, no long contract needed
- $89/mo semaglutide or $139/mo tirzepatide on a 12-month plan
- Available in all 50 states
Comes asVial or under the tongue
Semaglutide$99/momonth to month (4-week supply); $89 on a 12-month planVisit Lttl Read our Lttl review - Overnight shipping#6
$39 first monthCompounded semaglutide from $97 a month
- $39 first month on every plan, then from $97/mo on the 12-month plan; tirzepatide $39, then from $177
- Provider review in about 24 hours; free overnight shipping
- Full refund if a provider does not approve you; LegitScript certified
Comes asVial
Semaglutide from$97/moon the 12-month plan, billed monthly after a $39 first monthVisit HealthRX Read our HealthRX review - Low yearly price#7
Black Friday: 25% off at checkoutCompounded semaglutide or tirzepatide from $96 a month on a yearly plan
- $186/mo month to month, cancel anytime; tirzepatide is the same price
- Same plan price at every dose
- A licensed provider reviews every visit; unlimited care-team messaging
Comes asVial
Semaglutide$96/moon the 12-month plan ($1,152 billed upfront); $186 month to monthVisit yourEra Read our yourEra review
Every 2027 change we could confirm, by date
| Date | Drug or group | What changes | Source |
|---|---|---|---|
| Employer plans | In Business Group on Health's 2027 Employer Healthcare Strategy Survey (127 employers), coverage of GLP-1s to treat obesity dropped from 72% of employers in 2025 to 60% in 2026. | Business Group on Health, 2027 Employer Healthcare Strategy Survey | |
| Zepbound (single-dose pen, KwikPen, KwikPen self-pay) | Lilly's Zepbound savings cards, including the KwikPen self-pay card, end on December 31, 2026; the card terms say "Card expires and savings end on 12/31/2026." Post-transaction reimbursement claims under the KwikPen self-pay card (when the 45-day refill price wasn't applied at the pharmacy) must be submitted by March 31, 2027. Lilly has not published 2027 card terms. | Lilly: Zepbound savings and support | |
| Wegovy pen, new patients | Novo Nordisk's $199 price for each of the first two monthly fills of Wegovy 0.25 and 0.5 mg, for new patients, runs through December 31, 2026. Novo Nordisk has not published its 2027 self-pay prices. | Novo Nordisk: Wegovy savings and support | |
| Wegovy (pens and tablets), Ozempic, Rybelsus | Novo Nordisk lowers the list price of Wegovy injection 2.4 mg and tablets 25 mg, Ozempic 0.5, 1 and 2 mg, and Rybelsus 7 and 14 mg to $675 a month from January 1, 2027. Novo Nordisk says the decision applies to all doses of these medicines, and that the list-price change does not affect its direct-to-patient self-pay prices. | Novo Nordisk press release, Feb 24, 2026 | |
| Semaglutide (Ozempic, Rybelsus, Wegovy) in Medicare Part D | The Medicare negotiated price for semaglutide (Ozempic, Rybelsus, Wegovy) is $274 for a 30-day supply from January 1, 2027 (CMS's single 30-day figure), 71% below the 2024 list price of $959. CMS's per-package examples: Ozempic 4 mg/3 mL pen $276.78, Rybelsus 7 mg (30 tablets) $276.78, Wegovy 2.4 mg (4 pens) $385.63. It is the price for uses your Part D plan covers; your copay still comes from your plan, and it does not add weight-loss coverage. | CMS fact sheet: negotiated prices for 2027 (Nov 2025) | |
| All Medicare Part D drugs | In 2027 the standard Part D deductible rises to $700 (from $615 in 2026) and the out-of-pocket threshold to $2,400 (from $2,100). | CMS CY 2027 Rate Announcement, Apr 6, 2026 | |
| Medicare Part D | CMS says the BALANCE model is not launching in Medicare in 2027; the Bridge was extended instead, ahead of a potential later start in Part D. CMS gives no date or terms for anything after December 31, 2027; it says only that BALANCE could potentially start in Part D later. | CMS: BALANCE model page (updated Sep 29, 2026) | |
| Zepbound KwikPens and vials | The Express Scripts 2027 National Preferred Formulary excludes Zepbound KwikPens and Zepbound vials. The preferred alternatives it lists are liraglutide, Foundayo, Wegovy HD, Wegovy pens, Wegovy tablets and Zepbound (single-dose) pens. | Express Scripts: 2027 National Preferred Formulary Exclusions | |
| Medicare Part D members who qualify | The Medicare GLP-1 Bridge, with a $50 copay for eligible Part D members, runs from July 1, 2026 and is extended through December 31, 2027. | CMS: Medicare GLP-1 Bridge (page updated Jul 13, 2026) | |
| Medicare telehealth visits | Federal law extends the Medicare telehealth flexibilities (visits from home with no rural or site rule, and audio-only visits) through December 31, 2027. | Consolidated Appropriations Act, 2026 (H.R. 7148), sec. 6209 |
Each source was re-read on Nov 8, 2026. Novo Nordisk and Lilly have not published 2027 self-pay terms; we re-check in early January and update this table.
If you pay cash
No maker has published a 2027 self-pay price. Novo Nordisk says its list-price cut does not change its direct-to-patient self-pay prices. Two dated offers end on December 31, 2026: Novo Nordisk's two $199 Wegovy fills for new patients and Lilly's Zepbound savings cards, including the KwikPen self-pay card.
Online programs set their own monthly prices. In the programs we compare, compounded semaglutide starts at $59 a month (SnagRx's pre-Black Friday sale price, locked in; the page counts down to a price increase; read Nov 12, 2026) and compounded tirzepatide at $96 a month on a 12-month plan billed upfront (read Nov 12, 2026). Compounded medicines are not FDA-approved; a compounding pharmacy makes them for you.
If you have insurance through work
From January 1, 2027, the list price of Wegovy, Ozempic and Rybelsus is $675 a month. That can lower your cost if you pay a percentage of the price (coinsurance) or are still in your deductible. With a flat copay, your plan sets the amount.
Express Scripts' 2027 National Preferred Formulary excludes Zepbound KwikPens and vials and lists Zepbound single-dose pens and Wegovy pens and tablets as preferred alternatives. Your plan may use a different formulary, so check your 2027 drug list.
Fewer employers cover GLP-1s to treat obesity: 60% in 2026, down from 72% in 2025, in Business Group on Health's 2027 survey of 127 employers. If yours is dropping it, see what to do when coverage ends.
If you have Medicare
The $50 Medicare GLP-1 Bridge runs through December 31, 2027. CMS says the BALANCE model will not launch in Medicare in 2027. CMS gives no date or terms for anything after December 31, 2027; it says only that BALANCE could potentially start in Part D later.
The $274 Medicare negotiated price for semaglutide (CMS's 30-day figure; its package price for a 4-pen box of Wegovy 2.4 mg is $385.63) starts January 1, 2027. It is what Medicare pays for uses your Part D plan covers, such as type 2 diabetes; it is not a weight-loss price and not your copay. The Part D deductible goes to $700 and the out-of-pocket threshold to $2,400.
By drug: Wegovy cost, Wegovy pill cost, Ozempic cost, Zepbound cost. Coverage: Medicare and GLP-1s, is Wegovy covered by insurance, losing GLP-1 coverage. Cards: savings cards.
What we left out, and why
- A 2027 cash price for Wegovy, Ozempic or Zepbound: none is published.
- What Medicare does after the Bridge: CMS has said only that BALANCE could come to Part D later.
Federal law extends the Medicare telehealth flexibilities (visits from home with no rural or site rule, and audio-only visits) through December 31, 2027. Source: Consolidated Appropriations Act, 2026 (H.R. 7148), sec. 6209.
Questions about GLP-1 prices in 2027
Are GLP-1 prices going down in 2027?
Two prices are: Novo Nordisk cuts Wegovy, Ozempic and Rybelsus to $675 a month from January 1, 2027, and Medicare's negotiated semaglutide price is $274 for covered Part D uses. Cash prices are a different number: Novo Nordisk says the list-price cut does not change self-pay prices, and neither maker has published 2027 self-pay prices yet.
What will Wegovy cost in 2027?
The list price is $675 a month from January 1, 2027. The self-pay price for 2027 is not published; the current $199 new-patient fills run through December 31, 2026. See Wegovy cost for today's prices.
Will the Zepbound savings card work in 2027?
Lilly's current Zepbound cards, including the KwikPen self-pay card, expire on December 31, 2026, and post-transaction reimbursement claims under the KwikPen self-pay card (when the 45-day refill price wasn't applied at the pharmacy) must be submitted by March 31, 2027. Lilly has not published 2027 card terms.
Will Medicare cover GLP-1s for weight loss in 2027?
Through the Medicare GLP-1 Bridge, yes, for Part D members who meet its rules: a $50 copay for Wegovy (pen or pill), Foundayo or Zepbound KwikPen through December 31, 2027. CMS gives no date or terms for anything after December 31, 2027; it says only that BALANCE could potentially start in Part D later.
Does the $274 Medicare price mean I pay $274?
No. It is the price Medicare's system uses for semaglutide where your Part D plan covers it. Your own cost is your plan's copay or coinsurance, within the $2,400 out-of-pocket cap for 2027.